Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Rinucumab Biosimilar – Anti-PDGFRB, PDGFR-1, CD140b mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Rinucumab Biosimilar - Anti-PDGFRB, PDGFR-1, CD140b mAb - Research Grade |
|---|---|
| Source | CAS 1569263-06-4 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Rinucumab,REGN-2176,REGN-2176-3 (combination of aflibercept and ricunumab),REGN2176,PDGFRB, PDGFR-1, CD140b,anti-PDGFRB, PDGFR-1, CD140b |
| Reference | PX-TA1400 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Rinucumab Biosimilar - Anti-PDGFRB, PDGFR-1, CD140b mAb - Research Grade
General information on Anti-PDGFRB/ PDGFR-1/CD140b[Homo sapiens] (Rinucumab) Monoclonal Antibody
Rinucumab is investigated for the treatment of Neovascular (“Wet”) Age-related Macular Degeneration (AMD).
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.